IPSC Financial Statements

Balance sheet, income statement, cash flow, and dividends for Century Therapeutics Inc (IPSC).


$85.88M Market Cap.

As of 03/19/2025 5:00 PM ET (MRY) • Disclaimer

IPSC Market Cap. (MRY)


IPSC Shares Outstanding (MRY)


IPSC Assets (MRY)


Total Assets

$353.22M

Total Liabilities

$191.85M

Total Investments

$161.67M

IPSC Income (MRY)


Revenue

$6.59M

Net Income

-$126.57M

Operating Expense

$144.73M

IPSC Cash Flow (MRY)


CF Operations

-$110.14M

CF Investing

$47.48M

CF Financing

$74.56M

IPSC Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

-

-

0%

-

IPSC Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$353,216,000 (-2.07%)

$360,691,000 (-25.87%)

$486,544,000 (11.24%)

$437,375,000 (309.62%)

Assets Current

$194,051,000 (9.64%)

$176,994,000 (-44.64%)

$319,721,000 (40.13%)

$228,154,000 (189.55%)

Assets Non-Current

$159,165,000 (-13.35%)

$183,697,000 (10.11%)

$166,823,000 (-20.26%)

$209,221,000 (647.78%)

Goodwill & Intangible Assets

$34,200,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$161,362,000 (-12.66%)

$184,750,000 (-38.97%)

$302,738,000 (-23.60%)

$396,238,000 (472.36%)

Property Plant & Equipment Net

$90,847,000 (-1.34%)

$92,081,000 (-17.59%)

$111,730,000 (60.02%)

$69,821,000 (181.80%)

Cash & Equivalents

$61,213,000 (24.16%)

$49,303,000 (-42.83%)

$86,244,000 (48.28%)

$58,162,000 (109.76%)

Accumulated Other Comprehensive Income

$324,000 (200.00%)

$108,000 (104.39%)

-$2,462,000 (-278.77%)

-$650,000 (-21566.67%)

Deferred Revenue

$109,164,000 (-5.69%)

$115,753,000 (-1.89%)

$117,988,000 (0%)

$0 (0%)

Total Investments

$161,669,000 (-24.63%)

$214,510,000 (-24.22%)

$283,087,000 (-6.37%)

$302,348,000 (509.63%)

Investments Current

$130,851,000 (4.34%)

$125,414,000 (-45.76%)

$231,233,000 (38.93%)

$166,434,000 (242.87%)

Investments Non-Current

$30,818,000 (-65.41%)

$89,096,000 (71.82%)

$51,854,000 (-61.85%)

$135,914,000 (12807.31%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$3,075,000 (12.19%)

$2,741,000 (-49.74%)

$5,454,000 (-28.20%)

$7,596,000 (-6.01%)

Accumulated Retained Earnings (Deficit)

-$782,337,000 (-19.30%)

-$655,771,000 (-26.33%)

-$519,098,000 (-33.73%)

-$388,166,000 (-32.78%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$4,374,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$48,960,000 (4.93%)

$46,658,000 (-4.66%)

$48,939,000 (99.74%)

$24,501,000 (14.95%)

Debt Current

$0 (0%)

$0 (0%)

$6,502,000 (525.79%)

$1,039,000 (0%)

Debt Non-Current

$48,960,000 (4.93%)

$46,658,000 (9.95%)

$42,437,000 (80.88%)

$23,462,000 (10.07%)

Total Liabilities

$191,854,000 (9.04%)

$175,941,000 (-4.28%)

$183,806,000 (346.81%)

$41,137,000 (23.07%)

Liabilities Current

$129,782,000 (627.23%)

$17,846,000 (-40.15%)

$29,817,000 (90.46%)

$15,655,000 (29.25%)

Liabilities Non-Current

$62,072,000 (-60.74%)

$158,095,000 (2.67%)

$153,989,000 (504.30%)

$25,482,000 (19.55%)

IPSC Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$6,589,000 (194.81%)

$2,235,000 (-57.01%)

$5,199,000 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$33,155,000 (-4.47%)

$34,706,000 (8.94%)

$31,857,000 (65.62%)

$19,235,000 (102.58%)

Research & Development Expense

$107,244,000 (15.68%)

$92,710,000 (-4.59%)

$97,173,000 (28.45%)

$75,648,000 (90.64%)

Operating Expenses

$144,726,000 (-2.73%)

$148,781,000 (7.01%)

$139,030,000 (46.53%)

$94,883,000 (76.04%)

Interest Expense

$0 (0%)

$540,000 (-62.24%)

$1,430,000 (12.16%)

$1,275,000 (234.65%)

Income Tax Expense

$1,790,000 (-4.84%)

$1,881,000 (1967.03%)

$91,000 (111.63%)

$43,000 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$126,566,000 (7.40%)

-$136,673,000 (-4.38%)

-$130,932,000 (-36.64%)

-$95,824,000 (-78.86%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$126,566,000 (7.40%)

-$136,673,000 (-4.38%)

-$130,932,000 (-36.64%)

-$95,824,000 (-78.86%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$126,566,000 (7.40%)

-$136,673,000 (-4.38%)

-$130,932,000 (-36.64%)

-$95,824,000 (-78.86%)

Weighted Average Shares

$78,648,958 (32.60%)

$59,314,389 (2.70%)

$57,755,842 (78.30%)

$32,392,554 (332.95%)

Weighted Average Shares Diluted

$78,648,958 (32.60%)

$59,314,389 (2.70%)

$57,755,842 (78.30%)

$32,392,554 (332.95%)

Earning Before Interest & Taxes (EBIT)

-$124,776,000 (7.06%)

-$134,252,000 (-3.74%)

-$129,411,000 (-36.93%)

-$94,506,000 (-77.66%)

Gross Profit

$6,589,000 (194.81%)

$2,235,000 (-57.01%)

$5,199,000 (0%)

$0 (0%)

Operating Income

-$138,137,000 (5.74%)

-$146,546,000 (-9.50%)

-$133,831,000 (-41.05%)

-$94,883,000 (-76.04%)

IPSC Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$47,482,000 (-22.33%)

$61,132,000 (565.66%)

-$13,128,000 (95.60%)

-$298,338,000 (-1210.97%)

Net Cash Flow from Financing

$74,563,000 (866.71%)

-$9,725,000 (-135.81%)

$27,158,000 (-93.50%)

$417,774,000 (776.02%)

Net Cash Flow from Operations

-$110,135,000 (-24.66%)

-$88,348,000 (-728.72%)

$14,052,000 (115.79%)

-$89,002,000 (-115.66%)

Net Cash Flow / Change in Cash & Cash Equivalents

$11,910,000 (132.24%)

-$36,941,000 (-231.55%)

$28,082,000 (-7.73%)

$30,434,000 (286.30%)

Net Cash Flow - Business Acquisitions and Disposals

-$9,608,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$57,244,000 (-23.54%)

$74,868,000 (328.40%)

$17,476,000 (106.90%)

-$253,368,000 (-2986.09%)

Capital Expenditure

-$154,000 (98.88%)

-$13,736,000 (55.12%)

-$30,604,000 (31.95%)

-$44,970,000 (-357.71%)

Issuance (Repayment) of Debt Securities

$0 (0%)

-$10,241,000 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$74,563,000 (14350.19%)

$516,000 (-98.10%)

$27,158,000 (-89.48%)

$258,146,000 (577.55%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$12,688,000 (-13.23%)

$14,622,000 (37.05%)

$10,669,000 (128.85%)

$4,662,000 (432.19%)

Depreciation Amortization & Accretion

$13,304,000 (12.29%)

$11,848,000 (17.64%)

$10,071,000 (119.79%)

$4,582,000 (161.23%)

IPSC Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00%

-

Profit Margin

-1920.90% (68.59%)

-6115.10% (-142.82%)

-2518.40%

-

EBITDA Margin

-1691.80% (69.11%)

-5476.70% (-138.59%)

-2295.40%

-

Return on Average Equity (ROAE)

-66.90% (-13.58%)

-58.90% (-55.00%)

-38.00% (-16.56%)

-32.60% (-160.37%)

Return on Average Assets (ROAA)

-33.60% (-0.30%)

-33.50% (-32.94%)

-25.20% (-11.01%)

-22.70% (58.12%)

Return on Sales (ROS)

-1893.70% (68.47%)

-6006.80% (-141.31%)

-2489.20%

-

Return on Invested Capital (ROIC)

-41.70% (-13.93%)

-36.60% (-20.00%)

-30.50% (3.17%)

-31.50% (60.87%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

-0.63 (56.55%)

-1.44 (36.15%)

-2.26 (57.82%)

-5.36

Price to Sales Ratio (P/S)

12.06 (-86.32%)

88.11 (54.61%)

56.99

-

Price to Book Ratio (P/B)

0.53 (-50.51%)

1.07 (7.61%)

1 (-54.32%)

2.19

Debt to Equity Ratio (D/E)

1.19 (24.89%)

0.95 (56.84%)

0.61 (483.65%)

0.1 (133.12%)

Earnings Per Share (EPS)

-1.61 (30.00%)

-2.3 (-1.32%)

-2.27 (23.31%)

-2.96 (58.66%)

Sales Per Share (SPS)

0.08 (121.05%)

0.04 (-57.78%)

0.09 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-1.4 (18.54%)

-1.72 (-499.65%)

-0.29 (93.06%)

-4.14 (39.43%)

Book Value Per Share (BVPS)

2.05 (-34.13%)

3.12 (-40.58%)

5.24 (-57.15%)

12.23 (186.00%)

Tangible Assets Book Value Per Share (TABVPS)

4.06 (-33.30%)

6.08 (-27.81%)

8.42 (-37.61%)

13.5 (-5.39%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (0.00%)

-1 (50.00%)

-2 (75.00%)

-8

Enterprise Value Over EBITDA (EV/EBITDA)

-0.73 (52.26%)

-1.53 (22.76%)

-1.98 (77.44%)

-8.77

Asset Turnover

0.02 (240.00%)

0.01 (-50.00%)

0.01 (0%)

0 (0%)

Current Ratio

1.5 (-84.93%)

9.92 (-7.51%)

10.72 (-26.42%)

14.57 (124.01%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$110,289,000 (-8.04%)

-$102,084,000 (-516.75%)

-$16,552,000 (87.65%)

-$133,972,000 (-162.21%)

Enterprise Value (EV)

$81,284,332 (-56.51%)

$186,901,094 (-20.80%)

$235,974,887 (-70.06%)

$788,218,287

Earnings Before Tax (EBT)

-$124,776,000 (7.43%)

-$134,792,000 (-3.02%)

-$130,841,000 (-36.60%)

-$95,781,000 (-78.78%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$111,472,000 (8.93%)

-$122,404,000 (-2.57%)

-$119,340,000 (-32.71%)

-$89,924,000 (-74.81%)

Invested Capital

$176,981,000 (-47.98%)

$340,200,000 (-18.89%)

$419,422,000 (8.08%)

$388,059,000 (339.72%)

Working Capital

$64,269,000 (-59.62%)

$159,148,000 (-45.10%)

$289,904,000 (36.43%)

$212,499,000 (218.66%)

Tangible Asset Value

$319,016,000 (-11.55%)

$360,691,000 (-25.87%)

$486,544,000 (11.24%)

$437,375,000 (309.62%)

Market Capitalization

$85,879,332 (-56.77%)

$198,652,094 (-34.34%)

$302,537,887 (-65.09%)

$866,612,287

Average Equity

$189,258,750 (-18.49%)

$232,181,500 (-32.58%)

$344,389,750 (17.21%)

$293,816,500 (396.38%)

Average Assets

$376,696,500 (-7.65%)

$407,907,250 (-21.60%)

$520,296,750 (23.24%)

$422,196,250 (327.17%)

Invested Capital Average

$299,467,750 (-18.47%)

$367,294,000 (-13.55%)

$424,876,000 (41.44%)

$300,388,500 (354.83%)

Shares

85,029,042 (42.11%)

59,834,968 (1.46%)

58,974,247 (7.93%)

54,641,380 (-0.33%)